Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | cytochrome p450-like protein, putative | 0.011 | 0.0044 | 0.0044 |
Leishmania major | mitogen-activated protein kinase 3, putative,map kinase 3, putative | 0.9352 | 1 | 1 |
Echinococcus multilocularis | proto oncogene tyrosine protein kinase LCK | 0.0207 | 0.0149 | 0.0149 |
Echinococcus multilocularis | protein tyrosine kinase | 0.1287 | 0.1313 | 0.1313 |
Schistosoma mansoni | tyrosine kinase | 0.1287 | 0.1313 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0412 | 0.0369 | 0.0364 |
Schistosoma mansoni | septate junction protein | 0.0111 | 0.0045 | 0.0347 |
Brugia malayi | Tyrosine-protein kinase abl-1 | 0.0618 | 0.0592 | 0.0587 |
Echinococcus multilocularis | geminin | 0.0189 | 0.0129 | 0.0129 |
Schistosoma mansoni | tyrosine kinase | 0.0207 | 0.0149 | 0.1138 |
Entamoeba histolytica | SH2-protein kinase domain containing protein | 0.0073 | 0.0005 | 0.0569 |
Echinococcus multilocularis | tyrosine protein kinase lyn tyrosine protein kinase blk | 0.0207 | 0.0149 | 0.0149 |
Brugia malayi | cytochrome P450 | 0.011 | 0.0044 | 0.0038 |
Brugia malayi | Protein kinase domain containing protein | 0.1302 | 0.1329 | 0.1324 |
Echinococcus granulosus | tyrosine protein kinase Src42A | 0.0207 | 0.0149 | 0.0149 |
Schistosoma mansoni | hypothetical protein | 0.0189 | 0.0129 | 0.0985 |
Echinococcus multilocularis | c Jun NH2 terminal kinase | 0.1203 | 0.1222 | 0.1222 |
Echinococcus granulosus | geminin | 0.0189 | 0.0129 | 0.0129 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0111 | 0.0045 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase Src64B | 0.0207 | 0.0149 | 0.0149 |
Schistosoma mansoni | tyrosine kinase | 0.0207 | 0.0149 | 0.1138 |
Echinococcus granulosus | tyrosine protein kinase Fyn | 0.0207 | 0.0149 | 0.0149 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.9352 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0111 | 0.0045 | 0.5 |
Echinococcus granulosus | discoidin domain containing receptor 2 | 0.0111 | 0.0045 | 0.0045 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0111 | 0.0045 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.011 | 0.0044 | 0.0038 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0111 | 0.0045 | 0.5 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0111 | 0.0045 | 0.0118 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0903 | 0.0899 | 0.0899 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0111 | 0.0045 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 | 0.011 | 0.0044 | 0.0038 |
Schistosoma mansoni | hypothetical protein | 0.0189 | 0.0129 | 0.0985 |
Echinococcus granulosus | tyrosine kinase|tyrosine protein kinase Fyn | 0.0175 | 0.0115 | 0.0115 |
Echinococcus granulosus | Coagulation factor 5 8 type C terminal | 0.0111 | 0.0045 | 0.0045 |
Brugia malayi | Cytochrome P450 family protein | 0.0396 | 0.0352 | 0.0347 |
Echinococcus granulosus | tyrosine kinase | 0.0175 | 0.0115 | 0.0115 |
Mycobacterium tuberculosis | Possible arabinofuranosyltransferase AftD | 0.0111 | 0.0045 | 1 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0111 | 0.0045 | 0.0118 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0162 | 0.0101 | 0.0095 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0111 | 0.0045 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase ABL1 | 0.1063 | 0.1071 | 0.1071 |
Schistosoma mansoni | tyrosine kinase | 0.103 | 0.1036 | 0.789 |
Brugia malayi | Cytochrome P450 family protein | 0.0162 | 0.0101 | 0.0095 |
Schistosoma mansoni | cytochrome P450 | 0.011 | 0.0044 | 0.0337 |
Echinococcus granulosus | tyrosine protein kinase Fyn | 0.0207 | 0.0149 | 0.0149 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0396 | 0.0352 | 0.0347 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.9352 | 1 | 1 |
Trypanosoma brucei | cytochrome P450, putative | 0.0162 | 0.0101 | 0.0101 |
Echinococcus granulosus | discoidin domain receptor | 0.0885 | 0.0879 | 0.0879 |
Loa Loa (eye worm) | CMGC/MAPK/JNK protein kinase | 0.1203 | 0.1222 | 0.1217 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0162 | 0.0101 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0885 | 0.0879 | 0.0874 |
Echinococcus granulosus | tyrosine protein kinase Lyn | 0.0247 | 0.0192 | 0.0192 |
Echinococcus granulosus | mitogen activated protein kinase 11 | 0.9352 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.0045 | 0.004 |
Brugia malayi | SRC-1 | 0.0207 | 0.0149 | 0.0144 |
Toxoplasma gondii | PA14 domain-containing protein | 0.0111 | 0.0045 | 0.0118 |
Loa Loa (eye worm) | CMGC/MAPK/P38 protein kinase | 0.9352 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0111 | 0.0045 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0111 | 0.0045 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.3658 | 0.3867 | 0.3863 |
Echinococcus multilocularis | c src tyrosine kinase | 0.0094 | 0.0027 | 0.0027 |
Echinococcus granulosus | tyrosine protein kinase Fyn | 0.0207 | 0.0149 | 0.0149 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.9352 | 1 | 1 |
Echinococcus granulosus | twitchin | 0.0085 | 0.0018 | 0.0018 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.9352 | 1 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.9352 | 1 | 1 |
Echinococcus granulosus | discoidin domain containing receptor 2 | 0.0111 | 0.0045 | 0.0045 |
Toxoplasma gondii | cytochrome p450 superfamily protein | 0.011 | 0.0044 | 0.0114 |
Trichomonas vaginalis | hypothetical protein | 0.0111 | 0.0045 | 0.5 |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0111 | 0.0045 | 0.5 |
Echinococcus granulosus | c-Jun N-terminal kinases | 0.1203 | 0.1222 | 0.1222 |
Echinococcus multilocularis | tyrosine protein kinase lyn lyn a protein tyrosine kinase lymphocyte specific protein tyrosine kinase | 0.0207 | 0.0149 | 0.0149 |
Schistosoma mansoni | tyrosine kinase | 0.0094 | 0.0027 | 0.0206 |
Echinococcus granulosus | tyrosine protein kinase Btk29A | 0.0094 | 0.0027 | 0.0027 |
Echinococcus multilocularis | tyrosine protein kinase HCK | 0.0142 | 0.0079 | 0.0079 |
Echinococcus granulosus | tyrosine protein kinase ABL1 | 0.1063 | 0.1071 | 0.1071 |
Echinococcus granulosus | mitogen activated protein kinase 14 | 0.9352 | 1 | 1 |
Schistosoma mansoni | discoidin domain receptor | 0.0111 | 0.0045 | 0.0347 |
Echinococcus multilocularis | tyrosine protein kinase Btk29A | 0.0094 | 0.0027 | 0.0027 |
Loa Loa (eye worm) | TK/FAK protein kinase | 0.1302 | 0.1329 | 0.1324 |
Trypanosoma cruzi | Lanosterol 14-alpha demethylase | 0.011 | 0.0044 | 0.0044 |
Leishmania major | cytochrome p450-like protein | 0.0162 | 0.0101 | 0.0101 |
Echinococcus granulosus | protein tyrosine kinase | 0.1287 | 0.1313 | 0.1313 |
Echinococcus granulosus | proto oncogene tyrosine protein kinase LCK | 0.0207 | 0.0149 | 0.0149 |
Loa Loa (eye worm) | hypothetical protein | 0.0168 | 0.0107 | 0.0102 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0111 | 0.0045 | 0.5 |
Trichomonas vaginalis | beta-hexosaminidase B, putative | 0.0111 | 0.0045 | 0.5 |
Echinococcus multilocularis | Coagulation factor 5 8 type, C terminal | 0.0111 | 0.0045 | 0.0045 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0111 | 0.0045 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0803 | 0.0791 | 0.0785 |
Schistosoma mansoni | hypothetical protein | 0.011 | 0.0044 | 0.0337 |
Echinococcus granulosus | c src tyrosine kinase | 0.0094 | 0.0027 | 0.0027 |
Leishmania major | cytochrome p450-like protein | 0.011 | 0.0044 | 0.0044 |
Schistosoma mansoni | serine/threonine protein kinase | 0.1203 | 0.1222 | 0.9312 |
Brugia malayi | hypothetical protein | 0.0168 | 0.0107 | 0.0102 |
Brugia malayi | Cytochrome P450 family protein | 0.0162 | 0.0101 | 0.0095 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0207 | 0.0149 | 0.0149 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.0045 | 0.004 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0111 | 0.0045 | 0.5 |
Echinococcus multilocularis | 0.011 | 0.0044 | 0.0044 | |
Trypanosoma brucei | mitogen-activated protein kinase 3, putative | 0.9352 | 1 | 1 |
Echinococcus granulosus | discoidin domain containing receptor 2 | 0.0111 | 0.0045 | 0.0045 |
Echinococcus multilocularis | discoidin domain containing receptor 2 | 0.0111 | 0.0045 | 0.0045 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0111 | 0.0045 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.3658 | 0.3867 | 1 |
Echinococcus multilocularis | tyrosine protein kinase Abl | 0.0477 | 0.0439 | 0.0439 |
Loa Loa (eye worm) | TK protein kinase | 0.0142 | 0.0079 | 0.0074 |
Entamoeba histolytica | protein kinase, putative | 0.0073 | 0.0005 | 0.0569 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0162 | 0.0101 | 0.0101 |
Onchocerca volvulus | 0.0111 | 0.0045 | 0.0462 | |
Trypanosoma cruzi | cytochrome P450, putative | 0.0162 | 0.0101 | 0.0101 |
Loa Loa (eye worm) | inward rectifying k channel family protein 1 | 0.3658 | 0.3867 | 0.3863 |
Echinococcus granulosus | tyrosine protein kinase HCK | 0.0142 | 0.0079 | 0.0079 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0162 | 0.0101 | 0.0095 |
Echinococcus multilocularis | tyrosine protein kinase Src42A | 0.0207 | 0.0149 | 0.0149 |
Echinococcus multilocularis | discoidin domain containing receptor 2 | 0.0111 | 0.0045 | 0.0045 |
Brugia malayi | Protein kinase domain containing protein | 0.0914 | 0.091 | 0.0905 |
Schistosoma mansoni | btb and poz domain-containing protein | 0.0111 | 0.0045 | 0.0347 |
Plasmodium vivax | LCCL domain-containing protein | 0.0111 | 0.0045 | 0.5 |
Entamoeba histolytica | protein kinase, putative | 0.0142 | 0.0079 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.3658 | 0.3867 | 0.3863 |
Brugia malayi | Stress-activated protein kinase jnk-1 | 0.1203 | 0.1222 | 0.1217 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0175 | 0.0115 | 0.0115 |
Echinococcus multilocularis | tyrosine protein kinase Fgr | 0.0207 | 0.0149 | 0.0149 |
Echinococcus granulosus | cytochrome P450 2K1 | 0.011 | 0.0044 | 0.0044 |
Echinococcus multilocularis | discoidin domain receptor | 0.0111 | 0.0045 | 0.0045 |
Schistosoma mansoni | hypothetical protein | 0.0111 | 0.0045 | 0.0347 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0111 | 0.0045 | 0.5 |
Schistosoma mansoni | discoidin domain receptor | 0.0111 | 0.0045 | 0.0347 |
Echinococcus multilocularis | tyrosine protein kinase Srms | 0.0175 | 0.0115 | 0.0115 |
Brugia malayi | protein-tyrosine kinase | 0.0175 | 0.0115 | 0.0109 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0111 | 0.0045 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0111 | 0.0045 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase Src42A | 0.0146 | 0.0084 | 0.0084 |
Loa Loa (eye worm) | TK/DDR protein kinase | 0.0803 | 0.0791 | 0.0785 |
Schistosoma mansoni | tyrosine kinase | 0.0094 | 0.0027 | 0.0206 |
Echinococcus granulosus | 3'partial|tyrosine protein kinase Fgr | 0.0207 | 0.0149 | 0.0149 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0111 | 0.0045 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.3658 | 0.3867 | 0.3863 |
Schistosoma mansoni | dock | 0.0111 | 0.0045 | 0.0347 |
Loa Loa (eye worm) | TK/ABL protein kinase | 0.1063 | 0.1071 | 0.1066 |
Echinococcus multilocularis | nuclear receptor 2C2 associated protein | 0.0111 | 0.0045 | 0.0045 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0207 | 0.0149 | 0.0149 |
Leishmania major | lanosterol 14-alpha-demethylase, putative | 0.011 | 0.0044 | 0.0044 |
Echinococcus granulosus | tyrosine protein kinase Blk | 0.0175 | 0.0115 | 0.0115 |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0111 | 0.0045 | 0.5 |
Echinococcus multilocularis | discoidin domain containing receptor 2 | 0.0111 | 0.0045 | 0.0045 |
Onchocerca volvulus | 0.0914 | 0.091 | 1 | |
Trypanosoma cruzi | Lanosterol 14-alpha demethylase | 0.011 | 0.0044 | 0.0044 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0162 | 0.0101 | 0.0095 |
Echinococcus multilocularis | tyrosine protein kinase Blk | 0.0175 | 0.0115 | 0.0115 |
Loa Loa (eye worm) | SRC-1 | 0.0207 | 0.0149 | 0.0144 |
Echinococcus granulosus | tyrosine protein kinase Src64B | 0.0207 | 0.0149 | 0.0149 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0111 | 0.0045 | 0.0118 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.9352 | 1 | 1 |
Echinococcus granulosus | macrophage colony stimulating factor 1 receptor | 0.1642 | 0.1695 | 0.1695 |
Plasmodium vivax | LCCL domain-containing protein | 0.0111 | 0.0045 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0207 | 0.0149 | 0.0149 |
Leishmania major | cytochrome p450-like protein | 0.011 | 0.0044 | 0.0044 |
Schistosoma mansoni | proto-oncogene tyrosine-protein kinase src | 0.0094 | 0.0027 | 0.0206 |
Echinococcus granulosus | tyrosine protein kinase Src42A | 0.0146 | 0.0084 | 0.0084 |
Trypanosoma brucei | Lanosterol 14-alpha demethylase | 0.011 | 0.0044 | 0.0044 |
Mycobacterium leprae | PROBABLE CONSERVED TRANSMEMBRANE PROTEIN | 0.0111 | 0.0045 | 1 |
Onchocerca volvulus | 0.0168 | 0.0107 | 0.1143 | |
Brugia malayi | Tyrosine-protein kinase abl-1 | 0.0477 | 0.0439 | 0.0434 |
Loa Loa (eye worm) | TK protein kinase | 0.0175 | 0.0115 | 0.0109 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0111 | 0.0045 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Average weight gain (functional) | = -1.3 g | Evaluated for antitumor activityt against B-16 melanoma in mice aat a dose 2 mg/kg day ,ip,on days 1, 4, and 7 against B-16 Melanoma cell | ChEMBL. | 6425501 |
Average weight gain (functional) | = -1.3 g | Evaluated for antitumor activityt against B-16 melanoma in mice aat a dose 2 mg/kg day ,ip,on days 1, 4, and 7 against B-16 Melanoma cell | ChEMBL. | 6425501 |
Average weight gain (functional) | = -0.6 g | Evaluated for antitumor activityt against B-16 melanoma in mice at a dose 4 mg/kg day ,ip, on days 1, 4, and 7 against B-16 Melanoma cell | ChEMBL. | 6425501 |
Average weight gain (functional) | = -0.6 g | Evaluated for antitumor activityt against B-16 melanoma in mice at a dose 4 mg/kg day ,ip, on days 1, 4, and 7 against B-16 Melanoma cell | ChEMBL. | 6425501 |
Average weight gain (functional) | = 0.6 g | Evaluated for antitumor activityt against B-16 melanoma in mice at a dose 6 mg/kg day ,ip, on days 1, 4, and 7 against B-16 Melanoma cell | ChEMBL. | 6425501 |
Average weight gain (functional) | = 0.6 g | Evaluated for antitumor activityt against B-16 melanoma in mice at a dose 6 mg/kg day ,ip, on days 1, 4, and 7 against B-16 Melanoma cell | ChEMBL. | 6425501 |
Average weight gain (functional) | = 0.9 g | Evaluated for antitumor activityt against B-16 melanoma in mice at a dose 8 mg/kg day ,ip, on days 1, 4, and 7 against B-16 Melanoma cell | ChEMBL. | 6425501 |
Average weight gain (functional) | = 0.9 g | Evaluated for antitumor activityt against B-16 melanoma in mice at a dose 8 mg/kg day ,ip, on days 1, 4, and 7 against B-16 Melanoma cell | ChEMBL. | 6425501 |
Cures (functional) | = 0 | Evaluated for antitumor activity against B-16 melanoma in mice at a dose 8 mg/kg day ,ip, on days 1, 4, and 7 against B-16 Melanoma cell *-Tumors survivors on day 62 | ChEMBL. | 6425501 |
Cures (functional) | = 0 | Evaluated for antitumor activityt against B-16 melanoma in mice at a dose 6 mg/kg day ,ip, on days 1, 4, and 7 against B-16 Melanoma cell *-Tumors survivors on day 62 | ChEMBL. | 6425501 |
Cures (functional) | = 0 | Evaluated for antitumor activityt against B-16 melanoma in mice at a dose 4 mg/kg day ,ip, on days 1, 4, and 7 against B-16 Melanoma cell *-Tumors survivors on day 62 | ChEMBL. | 6425501 |
Cures (functional) | = 0 | Evaluated for antitumor activityt against B-16 melanoma in mice at a dose 2 mg/kg day, ip, on days 1, 4, and 7 against B-16 Melanoma cell *-Tumors survivors on day 62 | ChEMBL. | 6425501 |
MED (functional) | = 0.2 mg kg-1 | Minimum effective dose against P388 leukemic cells | ChEMBL. | 6425501 |
MED (functional) | = 0.2 mg kg-1 | Minimum effective dose against P388 leukemic cells | ChEMBL. | 6425501 |
OD (functional) | = 12.8 mg kg-1 | Optimum dose (mg/kg) against P388 leukemic cells | ChEMBL. | 6425501 |
OD (functional) | = 12.8 mg kg-1 | Optimum dose (mg/kg) against P388 leukemic cells | ChEMBL. | 6425501 |
T/C (functional) | = 180 % | Evaluated for antitumor activityt against B-16 melanoma in mice at a dose 2 mg/kg day ,ip, on days 1, 4, and 7 against B-16 Melanoma cell | ChEMBL. | 6425501 |
T/C (functional) | = 180 % | Evaluated for antitumor activityt against B-16 melanoma in mice at a dose 2 mg/kg day ,ip, on days 1, 4, and 7 against B-16 Melanoma cell | ChEMBL. | 6425501 |
T/C (functional) | = 227 % | Evaluated for antitumor activity against B-16 melanoma in mice at a dose 8 mg/kg day ,ip, on days 1, 4, and 7 against B-16 Melanoma cell | ChEMBL. | 6425501 |
T/C (functional) | = 227 % | Evaluated for antitumor activity against B-16 melanoma in mice at a dose 8 mg/kg day ,ip, on days 1, 4, and 7 against B-16 Melanoma cell | ChEMBL. | 6425501 |
T/C (functional) | = 252 % | Evaluated for antitumor activityt against B-16 melanoma in mice at a dose 4 mg/kg day,ip, on days 1, 4, and 7 against B-16 Melanoma cell | ChEMBL. | 6425501 |
T/C (functional) | = 252 % | Evaluated for antitumor activityt against B-16 melanoma in mice at a dose 4 mg/kg day,ip, on days 1, 4, and 7 against B-16 Melanoma cell | ChEMBL. | 6425501 |
T/C (functional) | = 263 % | Evaluated for antitumor activityt against B-16 melanoma in mice at a dose 6 mg/kg day ,ip, on days 1, 4, and 7 against B-16 Melanoma cell | ChEMBL. | 6425501 |
T/C (functional) | = 263 % | Evaluated for antitumor activityt against B-16 melanoma in mice at a dose 6 mg/kg day ,ip, on days 1, 4, and 7 against B-16 Melanoma cell | ChEMBL. | 6425501 |
T/C (functional) | = 278 % | Maximum percent T/C (antitumor activity) against P388 leukemia cells for Mitomycin C | ChEMBL. | 6425501 |
T/C (functional) | = 278 % | Maximum percent T/C (antitumor activity) against P388 leukemia cells for Mitomycin C | ChEMBL. | 6425501 |
T/C (functional) | > 333 % | Maximum percent T/C (antitumor activity) against P388 leukemia cells for the compound. The number of 30-day survivors is given in the parenthesis. | ChEMBL. | 6425501 |
T/C (functional) | > 333 % | Maximum percent T/C (antitumor activity) against P388 leukemia cells for the compound. The number of 30-day survivors is given in the parenthesis. | ChEMBL. | 6425501 |
Therapeutic ratio (functional) | = 64 | Ratio of optimal dose (OD) and minimum effective dose (MED) required for antitumor activity in mice bearing P-388 lymphocytic leukemia | ChEMBL. | 6425501 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.